Pages that link to "Q42790878"
Jump to navigation
Jump to search
The following pages link to The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses (Q42790878):
Displaying 50 items.
- Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials (Q26744404) (← links)
- Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines (Q26744622) (← links)
- Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines (Q26783844) (← links)
- Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines (Q26800145) (← links)
- Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing (Q27003874) (← links)
- Influenza virus vaccines: lessons from the 2009 H1N1 pandemic (Q27027029) (← links)
- Influenza vaccination accelerates recovery of ferrets from lymphopenia (Q27321447) (← links)
- Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model (Q27330580) (← links)
- Influenza and Memory T Cells: How to Awake the Force (Q28070255) (← links)
- Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety (Q28079486) (← links)
- A history of influenza (Q28189170) (← links)
- The virosome concept for influenza vaccines (Q28262476) (← links)
- Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine (Q28728791) (← links)
- An interspecific Nicotiana hybrid as a useful and cost-effective platform for production of animal vaccines (Q28730453) (← links)
- Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France (Q28730980) (← links)
- Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009 (Q28741061) (← links)
- Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination (Q28742312) (← links)
- Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients (Q28743021) (← links)
- Universal influenza virus vaccines and therapeutic antibodies (Q30151337) (← links)
- Epitope specific T-cell responses against influenza A in a healthy population. (Q30202358) (← links)
- Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus (Q30205252) (← links)
- The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel (Q30223536) (← links)
- Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production (Q30227434) (← links)
- Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate (Q30229527) (← links)
- Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning (Q30230076) (← links)
- Intranasal immunization with inactivated influenza vaccine. (Q30322979) (← links)
- Long-term immunogenicity of the influenza vaccine at reduced intradermal and full intramuscular doses among healthy young adults (Q30352137) (← links)
- Increased transmissibility explains the third wave of infection by the 2009 H1N1 pandemic virus in England. (Q30352299) (← links)
- DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza. (Q30352934) (← links)
- Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany. (Q30353414) (← links)
- Virological and serological study of human infection with swine influenza A H1N1 virus in China. (Q30353979) (← links)
- Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine. (Q30357144) (← links)
- Avian influenza: a pandemic waiting in the wings? (Q30357794) (← links)
- Simplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine. (Q30358537) (← links)
- Influenza vaccination in immunocompromised patients: efficacy and safety. (Q30358640) (← links)
- Scientific barriers to developing vaccines against avian influenza viruses. (Q30360468) (← links)
- Seasonal influenza vaccination and technologies. (Q30360897) (← links)
- Quality and kinetics of the antibody response in mice after three different low-dose influenza virus vaccination strategies. (Q30362618) (← links)
- Characterization of pandemic influenza immune memory signature after vaccination or infection. (Q30363416) (← links)
- Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. (Q30363581) (← links)
- A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines. (Q30365391) (← links)
- Determinants of influenza transmission in South East Asia: insights from a household cohort study in Vietnam (Q30365932) (← links)
- Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection (Q30366832) (← links)
- Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination. (Q30368005) (← links)
- Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection. (Q30368742) (← links)
- Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. (Q30369076) (← links)
- Longevity and determinants of protective humoral immunity after pandemic influenza infection. (Q30369770) (← links)
- Hydrophobin fusion of an influenza virus hemagglutinin allows high transient expression in Nicotiana benthamiana, easy purification and immune response with neutralizing activity. (Q30370156) (← links)
- Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge. (Q30372105) (← links)
- Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs. (Q30372141) (← links)